FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
Express Scripts sues FTC over report blasting pharmacy middlemen
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen
Express Scripts sues FTC over report blaming pharmacy middlemen for high drug costs
At issue is a report released by the FTC in July called: “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” Express Scripts claims in the lawsuit that the report “is seventy-four pages of unsupported innuendo” leveled against it and other PBMs.
Pharmaceutical Strategies Group Publishes 2024 Pharmacy Benefit Manager Customer Satisfaction Report
The 2024 Pharmacy Benefit Manager Customer Satisfaction Report published by Pharmaceutical Strategies Group ("PSG") disclosed low satisfaction and demand for change in the industry amongst healthcare payers.
New Idaho law to reform pharmacy middlemen aims to lower drug costs
A new Idaho law that goes into effect in January reforms pharmacy benefit managers to increase transparency and cut prescription drug costs. The law requires reporting, bans certain practices and
Express Scripts sues Federal Trade Commission over 'false' report
Express Scripts Inc. on Tuesday sued the Federal Trade Commission in federal court in St. Louis, alleging that a July report made “unsubstantiated, false and biased claims” about the company.
Express Scripts sues FTC over a ‘biased’ report about pharmacy benefit managers
Express Scripts, one of the largest pharmacy benefit managers in the U.S., filed a lawsuit demanding that a recent FTC report on industry middlemen be vacated.
Pharmacy Benefit Management (PBM) Market to Surpass USD 934.9 billion by 2032 Driven by Innovation and Healthcare Spending
Market is Growing at CAGR of 6.0%, Increasing Demand for Cost-Effective Drug Management Solutions Propels Market Growth.Pune, ...
Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug ...
JD Supra3d
Recent Legislative Developments Impacting Pharmacy Benefit Managers, Health Plans & More
As prescription drug costs remains a significant, and largely bipartisan, issue for state and federal legislators, we ...
Benefits Pro10d
Pharmacy benefit managers, version 2.0 (post J&J lawsuit)
2025 and 2026, they're right around the corner, and many employers are making changes now for 2025 or are anticipating ...
New Idaho law to regulate pharmacy benefit managers. Will it reduce prescription drug costs?
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
KTVZ4h
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
Benefits Pro1d
How GLP-1s are shrinking waists but inflating your client's pharmacy spending
Treatments like GLP-1s are effective, but they're also extremely expensive. With GLP-1s rising in demand, it can pose a ...
The Washington Post on MSN1d
FTC sues pharmacy insurance managers, alleging unfair drug prices
The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S.